Avelumab Approved indication: Merkel cell carcinoma

被引：2
|
作者：
不详
机构：
来源：
AUSTRALIAN PRESCRIBER | 2018年 / 41卷 / 02期
关键词：
D O I：
10.18773/austprescr.2018.018
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
    Glutsch, Valerie
    Kneitz, Hermann
    Gesierich, Anja
    Goebeler, Matthias
    Haferkamp, Sebastian
    Becker, Juergen C.
    Ugurel, Selma
    Schilling, Bastian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 2087 - 2093
  • [42] BUDGET IMPACT ANALYSIS OF AVELUMAB IN PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN THE US
    Bharmal, M.
    D'Angelo, S. P.
    Phatak, H.
    VALUE IN HEALTH, 2017, 20 (09) : A424 - A424
  • [43] Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
    Valerie Glutsch
    Hermann Kneitz
    Anja Gesierich
    Matthias Goebeler
    Sebastian Haferkamp
    Jürgen C. Becker
    Selma Ugurel
    Bastian Schilling
    Cancer Immunology, Immunotherapy, 2021, 70 : 2087 - 2093
  • [44] Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
    Levy, Sonja
    Aarts, Maureen J. B.
    Eskens, Ferry A. L. M.
    Keymeulen, Kristien B. M., I
    Been, Lukas B.
    Grunhagen, Dirk
    van Akkooi, Alexander
    Jalving, Mathilde
    Tesselaar, Margot E. T.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [45] Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
    Min, Sandy Tun
    Nordman, Ina I. C.
    Tran, Huy A.
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 639 - 643
  • [46] Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma
    Dinoto, Alessandro
    McKeon, Andrew
    Vattemi, Gaetano
    Carta, Sara
    Ferrari, Sergio
    Mariotto, Sara
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 368
  • [47] COST-EFFECTIVENESS OF AVELUMAB IN THE TREATMENT OF PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN PORTUGAL
    Pinheiro, B.
    Silva Miguel, L.
    Alarcao, J.
    Palencia, R.
    Borges, M.
    VALUE IN HEALTH, 2020, 23 : S432 - S432
  • [48] Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma
    Kaufman, Howard L.
    Hunger, Matthias
    Hennessy, Meliessa
    Schlichting, Michael
    Bharmal, Murtuza
    FUTURE ONCOLOGY, 2018, 14 (03) : 255 - 266
  • [49] Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab.
    Badalamenti, Giuseppe
    Incorvaia, Lorena
    Algeri, Laura
    Carreca, Ignazio Ugo
    Brando, Chiara
    Madonia, Giorgio
    Peri, Marta
    Cucinella, Alessandra
    Perez, Alessandro
    Barraco, Nadia
    Russo, Tancredi Didier Bazan
    Pomi, Federica Li
    Carreca, Anna Paola
    Gristina, Valerio
    Galvano, Antonio
    Iovanna, Juan
    Fanale, Daniele
    Bazan, Viviana
    Russo, Antonio
    Carreca, Ignazio Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Avelumab Immunotherapy Management of adverse events associated with new treatment for Merkel cell carcinoma
    Ugolini, Heather
    Bryan, Jennifer
    Hennessy, Meliessa
    Kaufman, Howard L.
    D'Angelo, Sandra P.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (01) : E1 - E9
12345